• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由于致病性 TERT 变异和端粒缩短导致霍奇金淋巴瘤治疗后的严重治疗相关毒性。

Severe therapy-related toxicities after treatment for Hodgkin lymphoma due to a pathogenic TERT variant and shortened telomeres.

机构信息

Department of Pediatrics, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas.

Texas Children's Cancer and Hematology Centers, Texas Children's Hospital, Houston, Texas.

出版信息

Pediatr Blood Cancer. 2019 Aug;66(8):e27779. doi: 10.1002/pbc.27779. Epub 2019 May 2.

DOI:10.1002/pbc.27779
PMID:31050187
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7880543/
Abstract

Telomere biology disorders predispose affected individuals to specific malignancies and organ fibrosis in tissues sensitive to telomere length (TL) shortening, especially after exposure to chemotherapy and radiation. We report a case of a 17-year-old female with Hodgkin lymphoma who developed severe chemotherapy-related toxicities. She was subsequently found to have peripheral blood lymphocyte TL < 1st percentile and a pathogenic variant in TERT inherited from her father. This case demonstrates that early genetic evaluation of patients who experience greater than expected therapy-related toxicities may be warranted to help guide further decisions regarding therapy, imaging modalities, and lifelong cancer prevention surveillance.

摘要

端粒生物学紊乱使受影响的个体易患特定的恶性肿瘤和组织纤维化,这些组织对端粒长度 (TL) 缩短敏感,尤其是在接触化疗和辐射后。我们报告了一例 17 岁女性霍奇金淋巴瘤患者,她在化疗后出现严重的与治疗相关的毒性。随后发现她的外周血淋巴细胞 TL < 第 1 百分位,并且她从父亲那里遗传了 TERT 的致病性变异。该病例表明,对于经历大于预期的治疗相关毒性的患者,早期进行遗传评估可能是必要的,以帮助指导进一步的治疗、成像方式和终身癌症预防监测决策。

相似文献

1
Severe therapy-related toxicities after treatment for Hodgkin lymphoma due to a pathogenic TERT variant and shortened telomeres.由于致病性 TERT 变异和端粒缩短导致霍奇金淋巴瘤治疗后的严重治疗相关毒性。
Pediatr Blood Cancer. 2019 Aug;66(8):e27779. doi: 10.1002/pbc.27779. Epub 2019 May 2.
2
Abnormal telomere shortening of peripheral blood mononuclear cells and granulocytes in patients with chronic idiopathic neutropenia.慢性特发性中性粒细胞减少症患者外周血单个核细胞和粒细胞端粒缩短异常。
Haematologica. 2012 May;97(5):743-50. doi: 10.3324/haematol.2011.053983. Epub 2011 Dec 1.
3
Revisiting Telomere Shortening in Cancer.重新审视癌症中的端粒缩短。
Cells. 2019 Jan 31;8(2):107. doi: 10.3390/cells8020107.
4
The influence of TERC, TERT and ACYP2 genes polymorphisms on plasma telomerase concentration, telomeres length and T2DM.TERC、TERT 和 ACYP2 基因多态性对血浆端粒酶浓度、端粒长度和 T2DM 的影响。
Gene. 2021 Jan 15;766:145127. doi: 10.1016/j.gene.2020.145127. Epub 2020 Sep 13.
5
Telomerase gene mutations and telomere length shortening in patients with idiopathic pulmonary fibrosis in a Chinese population.中国人群特发性肺纤维化患者的端粒酶基因突变与端粒长度缩短
Respirology. 2015 Jan;20(1):122-8. doi: 10.1111/resp.12422. Epub 2014 Oct 23.
6
Telomere length shortening of peripheral blood mononuclear cells in solid-cancer patients undergoing standard-dose chemotherapy might be correlated with good treatment response and neutropenia severity.接受标准剂量化疗的实体癌患者外周血单个核细胞的端粒长度缩短可能与良好的治疗反应和中性粒细胞减少症严重程度相关。
Acta Haematol. 2007;118(1):30-7. doi: 10.1159/000101558. Epub 2007 Apr 11.
7
Novel variants in Nordic patients referred for genetic testing of telomere-related disorders.北欧患者中与端粒相关疾病的基因检测相关的新型变异。
Eur J Hum Genet. 2018 Jun;26(6):858-867. doi: 10.1038/s41431-018-0112-8. Epub 2018 Feb 26.
8
Telomere Length, TERT, and miRNA Expression.端粒长度、端粒酶逆转录酶及微小RNA表达
PLoS One. 2016 Sep 14;11(9):e0162077. doi: 10.1371/journal.pone.0162077. eCollection 2016.
9
A safety evaluation of brentuximab vedotin for the treatment of Hodgkin lymphoma.本妥昔单抗治疗霍奇金淋巴瘤的安全性评估。
Expert Opin Drug Saf. 2016 Jun;15(6):875-82. doi: 10.1080/14740338.2016.1179277. Epub 2016 May 5.
10
Mutations in XLF/NHEJ1/Cernunnos gene results in downregulation of telomerase genes expression and telomere shortening.XLF/NHEJ1/Cernunnos基因的突变导致端粒酶基因表达下调和端粒缩短。
Hum Mol Genet. 2017 May 15;26(10):1900-1914. doi: 10.1093/hmg/ddx098.

引用本文的文献

1
Pathogenic Loss-of-Function Germline Mutations in Patients With Solid Tumors.实体瘤患者的致病性种系功能丧失突变
JCO Precis Oncol. 2019 Oct 23;3. doi: 10.1200/PO.19.00230. eCollection 2019.

本文引用的文献

1
Understanding the evolving phenotype of vascular complications in telomere biology disorders.了解端粒生物学障碍中血管并发症的不断演变的表型。
Angiogenesis. 2019 Feb;22(1):95-102. doi: 10.1007/s10456-018-9640-7. Epub 2018 Aug 25.
2
Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up.十五年随访后国立癌症研究所遗传性骨髓衰竭综合征队列中的癌症。
Haematologica. 2018 Jan;103(1):30-39. doi: 10.3324/haematol.2017.178111. Epub 2017 Oct 19.
3
Shorter Remission Telomere Length Predicts Delayed Neutrophil Recovery After Acute Myeloid Leukemia Therapy: A Report From the Children's Oncology Group.较短的缓解期端粒长度可预测急性髓系白血病治疗后中性粒细胞恢复延迟:来自儿童肿瘤学组的报告
J Clin Oncol. 2016 Nov 1;34(31):3766-3772. doi: 10.1200/JCO.2016.66.9622.
4
Two-step mechanism involving active-site conformational changes regulates human telomerase DNA binding.涉及活性位点构象变化的两步机制调节人类端粒酶与DNA的结合。
Biochem J. 2015 Jan 15;465(2):347-57. doi: 10.1042/BJ20140922.
5
Many disease-associated variants of hTERT retain high telomerase enzymatic activity.许多与疾病相关的 hTERT 变异体保留了高端粒酶酶活性。
Nucleic Acids Res. 2013 Oct;41(19):8969-78. doi: 10.1093/nar/gkt653. Epub 2013 Jul 30.
6
The effect of chemotherapy on telomere dynamics: clinical results and possible mechanisms.化疗对端粒动力学的影响:临床结果及可能机制。
Leuk Lymphoma. 2013 Sep;54(9):2023-9. doi: 10.3109/10428194.2012.757765. Epub 2013 Jan 7.
7
Telomere dysfunction induced by chemotherapeutic agents and radiation in normal human cells.化疗药物和辐射诱导的正常人类细胞中端粒功能障碍。
Int J Biochem Cell Biol. 2012 Sep;44(9):1531-40. doi: 10.1016/j.biocel.2012.06.020. Epub 2012 Jun 20.
8
Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation.端粒 DNA 损伤是不可修复的,会导致持续的 DNA 损伤反应激活。
Nat Cell Biol. 2012 Mar 18;14(4):355-65. doi: 10.1038/ncb2466.
9
Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells.先天性角化不良诱导多能干细胞中端粒缩短和自我更新能力丧失。
Nature. 2011 May 22;474(7351):399-402. doi: 10.1038/nature10084.
10
TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements.骨髓衰竭患者的TERC和TERT基因突变及端粒长度测量的意义
Blood. 2009 Jan 8;113(2):309-16. doi: 10.1182/blood-2008-07-166421. Epub 2008 Oct 17.